This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
No clear criteria for inclusion in the review were stated.
Sources searched to identify primary studies
Not stated.
Criteria used to ensure the validity of primary studies
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
One randomised controlled trial, plus approximately 9 other studies of unknown design.
Methods of combining primary studies
The primary studies do not appear to have been combined. It is not clear how the primary studies were used to produce probabilities, or what those probabilities were.
Investigation of differences between primary studies
Sensitivity analyses were performed on the variability of primary data.
Results of the review
The main focus of the trial was the evaluation of excimer laser versus conventional angioplasty versus Nd/YAG laser assisted angioplasty for primary recanalisation. However, this model used data relating to the use of Nd/YAG in a secondary role to cross only those occlusions that the conventional guidewire could not recanalise. Based on a total of 7 patients, the laser's secondary recanalisation was 57% (4/7). Other published studies concluded that at least 50% of lesions that could not be crossed by guidewire could be recanalised by the laser.
Methods used to derive estimates of effectiveness
Where data was not available from the literature, an audit of patients' notes and expert opinion were used to estimate probabilities for the model.
Estimates of effectiveness and key assumptions
It was not stated where such methods were used in practice.
Measure of benefits used in the economic analysis
Quality-adjusted life years (QALYs) gained were estimated using a decision tree to estimate expected life years and a Markov model to extrapolate the short term recanalisation results over a 25 year period. The time trade-off and Euroqol visual analogue scales were used to estimate utilities from 36 health care professionals (100% response) and 36 members of the general public (3 of whom refused). Participants were interviewed by a trained research nurse who asked them to value 4 health states using the above mentioned techniques.
Direct costs
Direct health services costs were considered in terms of: initial recanalisation costs (unit costs for the angioplasty
